A detailed history of Greatmark Investment Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Greatmark Investment Partners, Inc. holds 4,090 shares of MRK stock, worth $402,210. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,090
Previous 4,290 4.66%
Holding current value
$402,210
Previous $531,000 12.62%
% of portfolio
0.06%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$111.15 - $128.97 $22,230 - $25,794
-200 Reduced 4.66%
4,090 $464,000
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $6,437 - $6,913
52 Added 1.23%
4,290 $531,000
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $14,155 - $16,493
125 Added 3.04%
4,238 $559,000
Q4 2023

Feb 05, 2024

SELL
$100.18 - $109.02 $22,540 - $24,529
-225 Reduced 5.19%
4,113 $448,000
Q3 2023

Nov 08, 2023

BUY
$102.95 - $114.33 $30,885 - $34,299
300 Added 7.43%
4,338 $446,000
Q2 2023

Aug 02, 2023

SELL
$108.61 - $118.38 $54,305 - $59,190
-500 Reduced 11.02%
4,038 $465,000
Q4 2022

Jan 30, 2023

BUY
$87.44 - $112.11 $4,372 - $5,605
50 Added 1.11%
4,538 $503,000
Q2 2022

Jul 28, 2022

SELL
$83.49 - $94.64 $33,396 - $37,856
-400 Reduced 8.18%
4,488 $409,000
Q1 2022

Apr 27, 2022

BUY
$73.51 - $82.4 $7,351 - $8,240
100 Added 2.09%
4,888 $401,000
Q3 2021

Nov 02, 2021

SELL
$71.68 - $78.83 $21,504 - $23,649
-300 Reduced 5.9%
4,788 $360,000
Q2 2021

Aug 23, 2021

BUY
$70.31 - $77.77 $49,217 - $54,439
700 Added 15.95%
5,088 $396,000
Q1 2021

May 04, 2021

BUY
$68.86 - $81.11 $5,164 - $6,083
75 Added 1.74%
4,388 $338,000
Q3 2019

Oct 30, 2019

BUY
$76.08 - $82.93 $328,133 - $357,677
4,313 New
4,313 $363,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Greatmark Investment Partners, Inc. Portfolio

Follow Greatmark Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.